Ken Griffin Outset Medical, Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Outset Medical, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 65,100 shares of OM stock, worth $40,362. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65,100
Previous 63,400
2.68%
Holding current value
$40,362
Previous $140,000
78.57%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding OM
# of Institutions
121Shares Held
37.6MCall Options Held
65.1KPut Options Held
91.3K-
Ameriprise Financial Inc Minneapolis, MN5.2MShares$3.22 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.82MShares$2.37 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY3.07MShares$1.91 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.65MShares$1.64 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.94MShares$1.2 Million0.0% of portfolio
About Outset Medical, Inc.
- Ticker OM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 48,007,300
- Market Cap $29.8M
- Description
- Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...